RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,517 | -16.3% | 1,405 | 0.0% | 0.00% | – |
| Q2 2023 | $1,812 | -2.3% | 1,405 | 0.0% | 0.00% | – |
| Q1 2023 | $1,855 | -7.2% | 1,405 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 1,405 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 1,405 | -6.6% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 1,505 | +7.1% | 0.00% | – |
| Q2 2021 | $6,000 | +20.0% | 1,405 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -79.2% | 1,405 | -86.5% | 0.00% | – |
| Q3 2020 | $24,000 | +9.1% | 10,405 | -12.6% | 0.00% | – |
| Q2 2020 | $22,000 | +144.4% | 11,905 | +104.1% | 0.00% | – |
| Q1 2020 | $9,000 | – | 5,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |